Table 2.
Body Mass Index, Lipid Profiles, Glucose Metabolism, and Number of Patients Taking Part in the CR Program in the STEMI and NSTEMI-UAP Groups
| STEMI (n=127) | NSTEMI-UAP (n=94) | |||
|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |
| Body mass index (kg/m2) | 23.7±3.2 | 23.3±2.9* | 25.3±3.2 | 24.6±2.9* |
| Lipid profile and glucose metabolism | ||||
| LDL-C (mg/dL) | 114±35 | 82±23* | 108±42 | 87±23 |
| HDL-C (mg/dL) | 42±15 | 45±13* | 42±11 | 47±12* |
| Triglyceride (mg/dL) | 159±98 | 125±47 | 133±63 | 154±107 |
| FBS (mg/dL) | 184±62 | 102±11* | 122±40† | 161±86 |
| HbA1c (%) | 6.2±0.8 | 6.1±0.5 | 6.3±0.9 | 6.6±1.2 |
| No. CR programs | ||||
| Early Phase II CR implementation (n) | 7.0±9.7 | 11.0±11.7† | ||
| Late Phase II CR implementation (n) | 12.8±12.5 | 15.5±13.2 | ||
| Total Phase II CR implementation (n) | 19.8±18.7 | 26.5±22.0† | ||
Data are presented as the mean±SD. *P<0.05 compared with baseline; †P<0.05 compared with the STEMI group. CR, cardiac rehabilitation. Other abbreviations as in Table 1.